Showing results (71-80 of 6,708) with videos related to

Sort By:
Pageof 671
Oncotargets and Therapy|October 3, 2019
MAGEC2 Correlates With Unfavorable Prognosis And Promotes Tumor Development In HCC Via Epithelial-Mesenchymal TransitionXuefeng Gu, Yuan Mao, Chuanbing Shi, et al.
Oncotargets and Therapy|October 3, 2019
Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancerDanyang Shen, Huan Wang, Qiming Zheng, et al.
Oncotargets and Therapy|July 30, 2019
Probe-based confocal laser endomicroscopy (pCLE) is a suitable method for extrapulmonary high grade neuroendocrine rectal carcinoma (HGNEC) evaluationRenato Cannizzaro, Stefania Maiero, Mara Fornasarig, et al.
Oncotargets and Therapy|July 30, 2019
Immune checkpoint inhibitors for small cell lung cancer: opportunities and challengesOrgilmaa Regzedmaa, Hongbing Zhang, Hongyu Liu, et al.
Oncotargets and Therapy|July 30, 2019
Association between potentially functional polymorphisms of chemokine family members and the survival of esophageal cancer patients in a Chinese populationJin-Lin Du, Ge-Nan Li, Rong-Wei He, et al.
Oncotargets and Therapy|July 30, 2019
Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expressionMin Wang, Yuan Xu, Guo-Zhong Wen, et al.
Oncotargets and Therapy|July 30, 2019
Studies on the treatment of melanoma with folate acid conjugated dextran and lauryl alcohol loaded with IMD0354Can Liu, Wei Chen, Zizi Chen, et al.
Oncotargets and Therapy|July 30, 2019
Effect of the imatinib treatment regimen on the postoperative prognosis of patients with high-risk gastrointestinal stromal tumorsYan-Shu Li, Wei Li, Qing-Sheng Zeng, et al.
Oncotargets and Therapy|July 30, 2019
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemiaAlessandro Broccoli, Clara Bertuzzi, Michelangelo Fiorentino, et al.
Oncotargets and Therapy|January 25, 2021
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic TargetsNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
Pageof 671